Just to add some additional perspective on Jorgensen, don't forget Trust was brought in as a consultant:

https://finance.yahoo.com/news/cellceutix-ret...00164.html

My opinion is Jorgensen may have stayed on until B phase 3 was set up to go. It's not like he's doing clinical trial work that any of us were aware of...